The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 278.00
Bid: 278.00
Ask: 285.00
Change: -2.00 (-0.71%)
Spread: 7.00 (2.518%)
Open: 272.00
High: 278.00
Low: 272.00
Prev. Close: 280.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Sep 2020 16:00

RNS Number : 6122Z
Fisher (James) & Sons plc
21 September 2020
 

21 September 2020

JAMES FISHER AND SONS PLC

(the "Company")

Director/PDMR Dealing

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

The Company was notified on 18 September 2020 that on that date, Mr Eoghan O'Lionaird, the Chief Executive Officer of the Company, purchased 4,329 Ordinary Shares of 25p each in the Company at an average price of 1148.56 pence per share.

Following this transaction Mr E O'Lionaird has a beneficial interest in the Company's issued ordinary share capital of 13,341 Ordinary Shares representing 0.03 per cent of the Company's total issued ordinary share capital.

 

The below information and notification is made in accordance with the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Eoghan O'Lionaird

2

Reason for Notification

a)

Position/status

Chief Executive Officer (PDMR)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

James Fisher and Sons plc

b)

LEI

213800J975E5OYR6S216

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 25 pence each in James Fisher and Sons plc

GB0003395000

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1141.87p

2177

1155.24p

2152

d)

Aggregated information

- Aggregated volume

- Price

 

4,329

1148.56p

e)

Date of the transaction

18 September 2020

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLBMTTMTMTBAM
Date   Source Headline
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings
13th Feb 20245:50 pmRNSHolding(s) in Company
8th Feb 20247:00 amRNSFull Year Trading Update
25th Jan 20247:00 amRNSAppointment of Independent Non-Executive Director
20th Dec 20236:06 pmRNSNotification of Director’s Interests in Shares
15th Dec 20233:07 pmRNSBLOCK LISTING SIX MONTHLY RETURN
22nd Nov 20234:06 pmRNSHolding(s) in Company
9th Nov 20231:59 pmRNSBoard Changes
26th Oct 20237:30 amRNSDirector Declaration
2nd Oct 20239:00 amRNSTotal Voting Rights and Share Capital
25th Sep 202311:29 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHalf year results
3rd Aug 20237:00 amRNSAppointment of Chief Financial Officer
17th Jul 20237:01 amRNSBoard Change
17th Jul 20237:00 amRNSHalf year trading update
6th Jul 20237:00 amRNSHolding(s) in Company
15th Jun 20233:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Jun 20234:18 pmRNSResults of Annual General Meeting (“AGM”)
14th Jun 20237:00 amRNSAGM Trading Statement
12th Jun 20234:24 pmRNSNotification of Directors' Interests in Shares
9th Jun 20233:53 pmRNSNotification of Directors' Interest in Shares
7th Jun 20237:00 amRNSCompletion of refinancing
12th May 20234:49 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
2nd May 20237:00 amRNSUpdate on full year results
28th Apr 20237:58 amRNSFull year results for the year ended 31 Dec 2022
26th Apr 20237:00 amRNSAgreed Revolving Credit Facility
28th Mar 20232:00 pmRNSHolding(s) in Company
24th Mar 20237:00 amRNSCorporate, Financing and Trading Update
6th Mar 20237:00 amRNSSale of JFN, Trading Update and Notice of Results
28th Dec 20227:00 amRNSSwordfish Dive Support Vessel sold for US$24m
19th Dec 20227:00 amRNSDisposal of three businesses
15th Dec 20224:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
19th Oct 20229:14 amRNSHolding(s) in Company
13th Sep 202212:59 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSCompany Secretary Change
29th Jul 20224:39 pmRNSHolding(s) in Company
23rd Jun 20222:06 pmRNSHolding(s) in Company
17th Jun 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 20224:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jun 20227:00 amRNSCEO Update
6th May 20225:42 pmRNSHolding(s) in Company
5th May 20225:05 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Statement
25th Apr 20221:42 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSAnnual Report and Notice of 2022 AGM posted
22nd Mar 20224:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.